Stock analysis, AI verdict, fundamentals & technical signals
Rating: NEUTRAL
Price: $0.27 Analyst target: $1.82 Upside: 564.23%
AEON Biopharma, Inc., a biopharmaceutical company, focuses on the development botulinum toxins for the treatment of debilitating medical conditions. The company is headquartered in Newport Beach, California.
See the full interactive analysis & chart →Informational only — not investment advice.